A carregar...

Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the Military Health System

BACKGROUND: Adjuvant radioactive iodine (RAI) for the treatment of differentiated thyroid cancer (DTC) has been associated with better prognosis, but, as of yet, no consensus has been reached on the best practices for RAI and data on the factors associated with its use are limited. Use of RAI and fa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mil Med
Main Authors: Gill, Abegail A., Enewold, Lindsey, Zahm, Shelia H., Shriver, Craig D., Zheng, Li, McGlynn, Katherine A., Zhu, Kangmin
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727906/
https://ncbi.nlm.nih.gov/pubmed/25181724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7205/MILMED-D-13-00540
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!